We found slightly decreased survival in RECQL4-knockdown glioma/MPNST cell lines due to increased apoptosis and a significantly increased susceptibility of such cell lines to ATR-kinase inhibitors. This evidence concerns the gene RECQL4 and central nervous system cancer.